By Business/Source
Currency:HKD
2025/FY
2025/FY
2025/H1
2024/FY
2024/H1
2023/FY
2023/H1
2022/FY
2022/H1
2021/FY
2021/H1
2020/FY
2020/H1
2019/FY
2016/FY
2016/H1
2015/FY
2015/H1
2014/FY
2014/H1
2013/FY
2013/H1
2012/FY
2012/H1
2011/FY
2011/H1
2009/H1
2008/FY
2008/H1
2007/FY
2007/H1
2006/FY
2006/H1
2005/FY
Stock NameRevenueRatio
生产及销售制药科技产品7.29B59.38%
生产及销售生物科技产品3.71B30.18%
生产及销售核药抗肿瘤诊疗及心脑血管精准介入诊疗科技产品1.28B10.44%
By Product
Currency:HKD
2025/FY
2025/FY
2025/H1
2024/FY
2024/H1
2023/FY
2023/H1
2022/FY
2022/H1
2021/FY
2021/H1
2020/FY
2020/H1
2019/FY
2016/FY
2016/H1
2015/FY
2015/H1
2014/FY
2014/H1
2013/FY
2013/H1
2012/FY
2012/H1
2011/FY
2011/H1
2009/H1
2008/FY
2008/H1
2007/FY
2007/H1
2006/FY
2006/H1
2005/FY
Stock NameRevenueRatio
生产及销售制药科技产品7.29B59.38%
生产及销售生物科技产品3.71B30.18%
生产及销售核药抗肿瘤诊疗及心脑血管精准介入诊疗科技产品1.28B10.44%
By Country/Region
Currency:HKD
2025/FY
2025/FY
2025/H1
2024/FY
2024/H1
2023/FY
2023/H1
2022/FY
2022/H1
2021/FY
2021/H1
2020/FY
2020/H1
2019/FY
2019/H1
2018/FY
2018/H1
2017/FY
2017/H1
2016/FY
2016/H1
2015/FY
2015/H1
2014/FY
2013/FY
2012/FY
2011/FY
2010/FY
2009/FY
2009/H1
2008/FY
2007/FY
2006/FY
2005/FY
Stock NameRevenueRatio
China10.63B86.51%
America759.42M6.18%
Europe432.68M3.52%
Asia (excl. China)408.91M3.33%
Other56.16M0.46%
